{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20220114",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "69897",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/206334Orig1s007ltr.pdf",
              "date": "20220119",
              "type": "Letter"
            },
            {
              "id": "69931",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206334s007lbl.pdf",
              "date": "20220120",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20191211",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "61254",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/206334Orig1s005ltr.pdf",
              "date": "20191212",
              "type": "Letter"
            },
            {
              "id": "61257",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206334s005lbl.pdf",
              "date": "20191212",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20140806",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "43519",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206334Orig1s000TOC.html",
              "date": "20140905",
              "type": "Review"
            },
            {
              "id": "44944",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/206334Orig1s000SumR.pdf",
              "date": "20140905",
              "type": "Summary Review"
            },
            {
              "id": "19716",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206334s000lbl.pdf",
              "date": "20140808",
              "type": "Label"
            },
            {
              "id": "32799",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/206334Orig1s000ltr.pdf",
              "date": "20140807",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20161017",
          "submission_public_notes": "Please see <a href=\"https://www.fda.gov/STIC/\">www.fda.gov/STIC</a> for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "45561",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/206334Orig1s003ltr.pdf",
              "date": "20161019",
              "type": "Letter"
            },
            {
              "id": "47277",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206334s003lbl.pdf",
              "date": "20170222",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20150714",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20210723",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "68187",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/206334s006lbl.pdf",
              "date": "20210726",
              "type": "Label"
            },
            {
              "id": "68201",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/206334Orig1s006ltr.pdf",
              "date": "20210727",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20180320",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "53250",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206334s004lbl.pdf",
              "date": "20180323",
              "type": "Label"
            },
            {
              "id": "53492",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/206334Orig1s004ltr.pdf",
              "date": "20180328",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20160120",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "40540",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206334s002lbl.pdf",
              "date": "20160126",
              "type": "Label"
            },
            {
              "id": "10562",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/206334Orig1s002ltr.pdf",
              "date": "20160121",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA206334",
      "sponsor_name": "MELINTA THERAP",
      "openfda": {
        "application_number": [
          "NDA206334"
        ],
        "brand_name": [
          "ORBACTIV"
        ],
        "generic_name": [
          "ORITAVANCIN"
        ],
        "manufacturer_name": [
          "Melinta Therapeutics, LLC"
        ],
        "product_ndc": [
          "70842-140"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "ORITAVANCIN"
        ],
        "rxcui": [
          "1547615",
          "1547620"
        ],
        "spl_id": [
          "4c7649f3-4d38-47e2-aa0d-2ed606bb930a"
        ],
        "spl_set_id": [
          "ff09a726-9f9b-4e30-b509-396781293220"
        ],
        "package_ndc": [
          "70842-140-01",
          "70842-140-03"
        ],
        "nui": [
          "N0000191281",
          "M000640741",
          "N0000182140",
          "N0000185504",
          "N0000185506",
          "N0000191267"
        ],
        "pharm_class_epc": [
          "Lipoglycopeptide Antibacterial [EPC]"
        ],
        "pharm_class_cs": [
          "Lipoglycopeptides [CS]"
        ],
        "pharm_class_moa": [
          "Cytochrome P450 2C19 Inhibitors [MoA]",
          "Cytochrome P450 2C9 Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inducers [MoA]",
          "Cytochrome P450 2D6 Inducers [MoA]"
        ],
        "unii": [
          "PUG62FRZ2E"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ORBACTIV",
          "active_ingredients": [
            {
              "name": "ORITAVANCIN DIPHOSPHATE",
              "strength": "EQ 400MG BASE/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}